Cargando…
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
BACKGROUND: Prostate-specific membrane antigen (PSMA) is overexpressed in the neovasculature of renal cell carcinoma (RCC). However, there remains limited evidence regarding the use of PSMA positron emission tomography/computed tomography (PET/CT) in RCC. OBJECTIVE: To assess the impact of PSMA PET/...
Autores principales: | Udovicich, Cristian, Callahan, Jason, Bressel, Mathias, Ong, Wee Loon, Perera, Marlon, Tran, Ben, Azad, Arun, Haran, Shankar, Moon, Daniel, Chander, Sarat, Shaw, Mark, Eapen, Renu, Goad, Jeremy, Lawrentschuk, Nathan, Murphy, Declan G., Hofman, Michael, Siva, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520507/ https://www.ncbi.nlm.nih.gov/pubmed/36185587 http://dx.doi.org/10.1016/j.euros.2022.08.001 |
Ejemplares similares
-
(68)Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
por: Udovicich, Cristian, et al.
Publicado: (2017) -
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol
por: Pryor, David, et al.
Publicado: (2021) -
Acute Interstitial Nephritis on Positron-Emission Tomography-Computed Tomography Imaging
por: Miao, Jing, et al.
Publicado: (2022) -
Quantitative assessment of ventilation-perfusion relationships with gallium-68 positron emission tomography/computed tomography imaging in lung cancer patients
por: Li, Zhuorui, et al.
Publicado: (2022) -
In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on (99m)Tc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination
por: Papathomas, Thomas, et al.
Publicado: (2020)